Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Swedish Orphan Biovitrum

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Anita MacDonald

Anita.MacDonald@NHS.Net

Moderately Similar
1 trials

Shared therapeutic areas:

Tyrosinemia, Type I
Similarity Score30%

Erik Brouwer, MD

Swedish Orphan Biovitrum

Moderately Similar
3 trials

Shared therapeutic areas:

Tyrosinemia, Type I

Worked with same sponsors:

Swedish Orphan Biovitrum
Similarity Score30%

Anita MacDonald, Professor

Birmingham Children´s Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Tyrosinemia, Type I
Similarity Score30%

André Nell

+27 51 410 3046

Moderately Similar
2 trials

Shared therapeutic areas:

Tyrosinemia, Type I
Similarity Score30%

Jess G. Thoene

University of Michigan

Moderately Similar
1 trials

Shared therapeutic areas:

Tyrosinemia, Type I
Similarity Score30%

Xiaoping Luo, MD, PhD

Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology

Moderately Similar
1 trials

Shared therapeutic areas:

Tyrosinemia, Type I

Worked with same sponsors:

Swedish Orphan Biovitrum
Similarity Score30%

André Nell

Bloemfontein Early Phase Clinical Unit, PAREXEL Internation (South Africa)

Moderately Similar
1 trials

Shared therapeutic areas:

Tyrosinemia, Type I
Similarity Score30%

Peter Bauer, Prof.

Centogene GmbH

Moderately Similar
25 trials

Shared therapeutic areas:

Tyrosinemia, Type I
Similarity Score30%

Curt Scharfe, MD, PhD

RTI International

Moderately Similar
1 trials

Shared therapeutic areas:

Tyrosinemia, Type I
Similarity Score30%

Ioannis Kottakis, MD, PhD

Swedish Orphan Biovitrum

Moderately Similar
1 trials

Shared therapeutic areas:

Tyrosinemia, Type I

Worked with same sponsors:

Swedish Orphan Biovitrum
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02323529Phase 3StudyDirector

Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1

Hereditary Tyrosinemia, Type I
Completed

All 1 trials loaded